Abstract

Purpose of review HIV requires lifelong antiviral treatment due to the persistence of a reservoir of latently infected cells. Multiple strategies have been pursued to promote the death of infected cells. Recent findings Several groups have focused on multipronged approaches to induce apoptosis of infected cells. One approach is to combine latency reversal agents with proapoptotic compounds and cytotoxic T cells to first reactivate and then clear infected cells. Other strategies include using natural killer cells or chimeric antigen receptor cells to decrease the size of the reservoir. A novel strategy is to promote cell death by pyroptosis. This mechanism relies on the activation of the caspase recruitment domain-containing protein 8 (CARD8) inflammasome by the HIV protease and can be potentiated by nonnucleoside reverse transcriptase inhibitors. Summary The achievement of a clinically significant reduction in the size of the reservoir will likely require a combination strategy since none of the approaches pursued so far has been successful on its own in clinical trials. This discrepancy between promising in vitro findings and modest in vivo results highlights the hurdles of identifying a universally effective strategy given the wide heterogeneity of the HIV reservoirs in terms of tissue location, capability to undergo latency reversal and susceptibility to cell death.

Original languageEnglish
Pages (from-to)56-61
Number of pages6
JournalCurrent Opinion in HIV and AIDS
Volume19
Issue number2
DOIs
StatePublished - Mar 1 2024

Keywords

  • HIV
  • apoptosis
  • latency
  • pyroptosis
  • reservoir

Fingerprint

Dive into the research topics of 'Pharmacological approaches to promote cell death of latent HIV reservoirs'. Together they form a unique fingerprint.

Cite this